Table 1.

Baseline characteristics at enrollment of subjects who completed all 3 arms of the study

Number of subjects	9 (5 female)
Glucocorticoid regimen prior to entering the study	Hydrocortisone (7), prednisone (2)
Dose of hydrocortisone (mg/m2/day) equivalent	15.6 ± 4.0
Age (years)	8.1 ± 2.3
Bone age (years)	8.6 ± 2.9
Height (cm); z-score	127.6 ± 17.9; 0.0 ± 1.2
Weight (kg); z-score	39.1 ± 24.0; 1.0 ± 1.4
BMI (kg/m2); z-score	22.0 ± 8.1; 1.2 ± 1.1
17-hydroxyprogesterone (ng/dL)	991.1 ± 978.5 89.4 (0.4–2500.0)
Androstenedione (ng/dL)	35.2 ± 22.5 22.3 (2.0–392.0)

Values are mean ± standard deviation, with 17-hydroxyprogesterone and androstenedione also including median (minimum – maximum) due to data skewness